We are live on ! Find out more
ADIM

Alpha DNA Investment Management Portfolio holdings

AUM $8.98M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+7%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
10 Year Est. Return
AUM
$263M
AUM Growth
-$4.42M
Cap. Flow
-$7.23M
Cap. Flow %
-2.75%
Top 10 Hldgs %
45.01%
Holding
265
New
72
Increased
63
Reduced
52
Closed
76

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$3.73M
2
MCD icon
McDonald's
MCD
+$3.07M
3
ADI icon
Analog Devices
ADI
+$2.85M
4
WFC icon
Wells Fargo
WFC
+$2.74M
5
MS icon
Morgan Stanley
MS
+$2.6M

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$3.81M
2
BAC icon
Bank of America
BAC
+$2.79M
3
VZ icon
Verizon
VZ
+$2.35M
4
PG icon
Procter & Gamble
PG
+$2.07M
5
NEE icon
NextEra Energy
NEE
+$2.03M

Sector Composition

Rank Sector Weight
1 Technology 21.23%
2 Financials 14.68%
3 Healthcare 9.28%
4 Consumer Discretionary 7.05%
5 Industrials 5.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMCL icon
151
Omnicell
OMCL
$1.68B
$429K 0.16%
+9,626
New +$432K
UFPT icon
152
UFP Technologies
UFPT
$2.49B
$428K 0.16%
+1,752
New +$510K
QCRH icon
153
QCR Holdings
QCRH
$1.71B
$427K 0.16%
5,299
-849
-14% -$71.4K
PSN icon
154
Parsons
PSN
$5.15B
$427K 0.16%
+4,626
New +$472K
LITE icon
155
Lumentum
LITE
$63.8B
$426K 0.16%
+5,074
New +$395K
NIC icon
156
Nicolet Bankshares
NIC
$3.72B
$426K 0.16%
+4,056
New +$428K
PHM icon
157
Pultegroup
PHM
$25.2B
$424K 0.16%
3,895
-3,616
-48% -$469K
FBK icon
158
FB Financial Corp
FBK
$3.07B
$423K 0.16%
8,216
-428
-5% -$22.3K
THC icon
159
Tenet Healthcare
THC
$20.9B
$423K 0.16%
3,352
+307
+10% +$45.6K
MTSI icon
160
MACOM Technology Solutions
MTSI
$22.9B
$423K 0.16%
+3,253
New +$409K
ICHR icon
161
Ichor Holdings
ICHR
$2.53B
$421K 0.16%
+13,056
New +$404K
MPC icon
162
Marathon Petroleum
MPC
$94.5B
$420K 0.16%
3,010
+164
+6% +$25K
G icon
163
Genpact
G
$5.71B
$419K 0.16%
+9,756
New +$412K
PCTY icon
164
Paylocity
PCTY
$7.7B
$418K 0.16%
+2,094
New +$401K
EPAM icon
165
EPAM Systems
EPAM
$5.15B
$415K 0.16%
+1,777
New +$395K
QLYS icon
166
Qualys
QLYS
$6.51B
$411K 0.16%
+2,931
New +$408K
BILL icon
167
BILL Holdings
BILL
$4.93B
$410K 0.16%
+4,842
New +$361K
BTSG icon
168
BrightSpring Health Services
BTSG
$11.5B
$408K 0.16%
+23,982
New +$415K
RBRK icon
169
Rubrik
RBRK
$20B
$407K 0.16%
6,229
-6,545
-51% -$323K
CDNA icon
170
CareDx
CDNA
$2.44B
$406K 0.15%
18,983
+3,880
+26% +$94.4K
CSTL icon
171
Castle Biosciences
CSTL
$985M
$404K 0.15%
15,174
-1,589
-9% -$48.4K
RITM icon
172
Rithm Capital
RITM
$5.72B
$403K 0.15%
37,188
+2,484
+7% +$26.9K
WGS icon
173
GeneDx Holdings
WGS
$2.44B
$403K 0.15%
5,238
-4,998
-49% -$349K
OSK icon
174
Oshkosh
OSK
$9.62B
$398K 0.15%
4,187
-1,609
-28% -$168K
CPF icon
175
Central Pacific Financial
CPF
$996M
$398K 0.15%
+13,688
New +$407K

Similar funds

Alpha DNA Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, Alpha DNA Investment Management held 265 positions worth $263M, down 1.7% from $267M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Alpha DNA Investment Management's Q4 2024 filing shows 72 new, 63 increased, 52 reduced and 76 closed positions. Its largest new stake was Palo Alto Networks: 6,205 shares worth $1.13M. The largest sale was Walmart Inc, an estimated $3.81M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Alpha DNA Investment Management's largest Q4 2024 buy was Palo Alto Networks: 6,205 shares worth $1.13M.
  • Alpha DNA Investment Management added most to Accenture in Q4 2024, an estimated $3.73M increase.
  • Alpha DNA Investment Management's biggest Q4 2024 reduction was Walmart Inc, cutting an estimated $3.81M.
  • Alpha DNA Investment Management fully exited Verizon in Q4 2024, selling an estimated $2.35M.
  • Alpha DNA Investment Management's ten largest holdings make up 45% of its $263M portfolio in Q4 2024.
  • Alpha DNA Investment Management opened 72 new positions and closed 76 in Q4 2024.
  • Alpha DNA Investment Management's portfolio value fell 1.7% quarter-over-quarter to $263M.

Based on Alpha DNA Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.